Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know

Bone Marrow Transplantation volume 50, pages 1030–1036 (2015)Cite this article

Subjects

Abstract

Human herpesvirus-6 (HHV-6) encephalitis following allogeneic hematopoietic cell transplantation is a serious and often fatal complication accompanying reactivation of HHV-6B. Incidence varies among studies, but is reportedly 0–11.6% after bone marrow or PBSC transplantation and 4.9–21.4% after umbilical cord blood transplantation, typically around 2–6 weeks post transplant. Symptoms are characterized by memory loss, loss of consciousness and seizures. Magnetic resonance imaging (MRI) typically shows bilateral signal abnormalities in the limbic system. This complication is considered to represent acute encephalitis caused by direct virally induced damage to the central nervous system, but our understanding of the etiologies and pathogenesis is still limited. The mortality rate attributable to this pathology remains high, and survivors are often left with serious sequelae such as impaired memory and epilepsy. Despite the poor prognosis, no validated treatments or preventative measures have been established. Establishment of preventative strategies represents an important challenge. This article reviews the current knowledge of the clinical features, incidence, pathogenesis and treatment of HHV-6 encephalitis, and discusses issues needing clarification in the future to overcome this serious complication.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M . Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 932–940.

    PubMed  Google Scholar 

  2. Hentrich M, Oruzio D, Jager G, Schlemmer M, Schleuning M, Schiel X et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005; 128: 66–72.

    PubMed  Google Scholar 

  3. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193: 68–79.

    CAS  PubMed  Google Scholar 

  4. Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007; 13: 100–106.

    Article  CAS  PubMed  Google Scholar 

  5. Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 2013; 57: 671–681.

    PubMed  Google Scholar 

  6. Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111: 774–781.

    CAS  PubMed  Google Scholar 

  7. Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, Kohno K et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008; 41: 279–285.

    CAS  PubMed  Google Scholar 

  8. Ogata M, Satou T, Kawano R, Takakura S, Goto K, Ikewaki J et al. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2010; 45: 129–136.

    CAS  PubMed  Google Scholar 

  9. Drobyski WR, Knox KK, Majewski D, Carrigan DR . Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–1360.

    CAS  PubMed  Google Scholar 

  10. Adams MJ, Carstens EB . Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses. Arch Virol 2012; 157: 1411–1422.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768–776.

    CAS  PubMed  Google Scholar 

  12. Reddy S, Manna P . Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant 2005; 11: 530–541.

    CAS  PubMed  Google Scholar 

  13. Kadakia MP, Rybka WB, Stewart JA, Patton JL, Stamey FR, Elsawy M et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996; 87: 5341–5354.

    CAS  PubMed  Google Scholar 

  14. Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P . Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28: 562–568.

    CAS  PubMed  Google Scholar 

  15. Zerr DM, Ogata M . HHV-6A and HHV-6B in recipients of hematopoietic cell transplantation. In: Flamand L, Lautenschlager I, Krueger G, Ablashi D (eds). Human Herpesviruses HHV-6A, HHV-6B & HHV-7. Diagnosis and Clinical Management 3rd edn. Elsevier: Kidlington, Oxford, UK, 2014 pp 217–234.

    Google Scholar 

  16. Hill AB . The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295–300.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Weed DL . On the use of causal criteria. Int J Epidemiol 1997; 26: 1137–1141.

    CAS  PubMed  Google Scholar 

  18. Zerr DM, Fann JR, Breiger D, Boeckh M, Adler AL, Xie H et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011; 117: 5243–5249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Johnston RE, Geretti AM, Prentice HG, Clark AD, Wheeler AC, Potter M et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999; 105: 1041–1043.

    CAS  PubMed  Google Scholar 

  20. Lagadinou ED, Marangos M, Liga M, Panos G, Tzouvara E, Dimitroulia E et al. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. Transpl Infect Dis 2010; 12: 437–440.

    CAS  PubMed  Google Scholar 

  21. Le Bourgeois A, Labopin M, Guillaume T, Delaunay J, Foucher Y, Tessoulin B et al. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Exp Hematol 2014; 42: 945–954.

    CAS  PubMed  Google Scholar 

  22. Cone RW, Hackman RC, Huang ML, Bowden RA, Meyers JD, Metcalf M et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993; 329: 156–161.

    CAS  PubMed  Google Scholar 

  23. Nakayama T, Okada F, Ando Y, Honda K, Ogata M, Goto K et al. A case of pneumonitis and encephalitis associated with human herpesvirus 6 (HHV-6) infection after bone marrow transplantation. Br J Radiol 2010; 83: e255–e258.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Amo K, Tanaka-Taya K, Inagi R, Miyagawa H, Miyoshi H, Okusu I et al. Human herpesvirus 6B infection of the large intestine of patients with diarrhea. Clin Infect Dis 2003; 36: 120–123.

    PubMed  Google Scholar 

  25. Zerr DM, Boeckh M, Delaney C, Martin PJ, Xie H, Adler AL et al. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1700–1708.

    PubMed  PubMed Central  Google Scholar 

  26. Dulery R, Salleron J, Dewilde A, Rossignol J, Boyle EM, Gay J et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Biol Blood Marrow Transplant 2012; 18: 1080–1089.

    PubMed  Google Scholar 

  27. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2012; 22: 144–155.

    CAS  PubMed  Google Scholar 

  28. Leong HN, Tuke PW, Tedder RS, Khanom AB, Eglin RP, Atkinson CE et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 2007; 79: 45–51.

    CAS  PubMed  Google Scholar 

  29. Hall CB, Caserta MT, Schnabel K, Shelley LM, Marino AS, Carnahan JA et al. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 2008; 122: 513–520.

    PubMed  Google Scholar 

  30. Gravel A, Hall CB, Flamand L . Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus. J Infect Dis 2013; 207: 1585–1589.

    CAS  PubMed  Google Scholar 

  31. Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara T, Shimizu N et al. Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. Clin Infect Dis 2014; 59: 545–548.

    PubMed  Google Scholar 

  32. Hill JA, Sedlak RH, Zerr DM, Huang ML, Yeung C, Myerson D et al. Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous system dysfunction. Biol Blood Marrow Transplant 2015; 21: 371–373.

    PubMed  Google Scholar 

  33. Lee SO, Brown RA, Razonable RR . Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis 2012; 14: 346–354.

    CAS  PubMed  Google Scholar 

  34. Clark DA, Nacheva EP, Leong HN, Brazma D, Li YT, Tsao EH et al. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 2006; 193: 912–916.

    PubMed  Google Scholar 

  35. Ward KN, Leong HN, Nacheva EP, Howard J, Atkinson CE, Davies NW et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 2006; 44: 1571–1574.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Zerr DM . Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006; 37: S52–S56.

    CAS  PubMed  Google Scholar 

  37. Muta T, Fukuda T, Harada M . Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant 2009; 43: 583–585.

    CAS  PubMed  Google Scholar 

  38. Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69: 156–165.

    CAS  PubMed  Google Scholar 

  39. Toriumi N, Kobayashi R, Yoshida M, Iguchi A, Sarashina T, Okubo H et al. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients. J Pediatr Hematol Oncol 2014; 36: 379–383.

    CAS  PubMed  Google Scholar 

  40. Kawaguchi T, Takeuchi M, Kawajiri C, Abe D, Nagao Y, Yamazaki A et al. Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation. Transpl Infect Dis 2013; 15: E54–E57.

    CAS  PubMed  Google Scholar 

  41. Ogata M, Satou T, Inoue Y, Takano K, Ikebe T, Ando T et al. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis. Bone Marrow Transplant 2013; 48: 257–264.

    CAS  PubMed  Google Scholar 

  42. Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant 2012; 18: 1638–1648.

    PubMed  Google Scholar 

  43. Howell KB, Tiedemann K, Haeusler G, Mackay MT, Kornberg AJ, Freeman JL et al. Symptomatic generalized epilepsy after HHV6 posttransplant acute limbic encephalitis in children. Epilepsia 2012; 53: e122–e126.

    PubMed  Google Scholar 

  44. Cheng FW, Lee V, Leung WK, Chan PK, Leung TF, Shing MK et al. HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis? Pediatr Transplant 2010; 14: 483–487.

    CAS  PubMed  Google Scholar 

  45. Bhanushali MJ, Kranick SM, Freeman AF, Cuellar-Rodriguez JM, Battiwalla M, Gea-Banacloche JC et al. Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology 2013; 80: 1494–1500.

    PubMed  PubMed Central  Google Scholar 

  46. Mori T, Mihara A, Yamazaki R, Shimizu T, Aisa Y, Suzuki S et al. Myelitis associated with human herpes virus 6 (HHV-6) after allogeneic cord blood transplantation. Scand J Infect Dis 2007; 39: 276–278.

    PubMed  Google Scholar 

  47. Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant 2010; 16: 1596–1602.

    PubMed  Google Scholar 

  48. Aoki K, Arima H, Kato A, Hashimoto H, Tabata S, Matsushita A et al. Human herpes virus 6-associated myelitis following allogeneic bone marrow transplantation. Ann Hematol 2012; 91: 1663–1665.

    PubMed  Google Scholar 

  49. Granerod J, Cunningham R, Zuckerman M, Mutton K, Davies NW, Walsh AL et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010; 138: 783–800.

    CAS  PubMed  Google Scholar 

  50. Dewhurst S . Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004; 11: 105a–111a.

    PubMed  Google Scholar 

  51. Ljungman P, de la Camara R, Cordonnier C, Einsele H, Engelhard D, Reusser P et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42: 227–240.

    CAS  PubMed  Google Scholar 

  52. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47: 303–327.

    CAS  PubMed  Google Scholar 

  53. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Fujimaki K, Mori T, Kida A, Tanaka M, Kawai N, Matsushima T et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006; 84: 432–437.

    CAS  PubMed  Google Scholar 

  55. Hill JA, Boeckh MJ, Sedlak RH, Jerome KR, Zerr DM . Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. J Clin Virol 2014; 61: 289–292.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Olson AL, Dahi PB, Zheng J, Devlin SM, Lubin M, Gonzales AM et al. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biol Blood Marrow Transplant 2014; 20: 787–793.

    PubMed  PubMed Central  Google Scholar 

  57. Betts BC, Young JA, Ustun C, Cao Q, Weisdorf DJ . Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant 2011; 17: 1562–1568.

    PubMed  PubMed Central  Google Scholar 

  58. Jeulin H, Agrinier N, Guery M, Salmon A, Clement L, Bordigoni P et al. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation. Transplantation 2013; 95: 1292–1298.

    PubMed  Google Scholar 

  59. Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R . Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 705–709.

    CAS  PubMed  Google Scholar 

  60. Sakai R, Kanamori H, Motohashi K, Yamamoto W, Matsuura S, Fujita A et al. Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1389–1394.

    PubMed  Google Scholar 

  61. Shimazu Y, Kondo T, Ishikawa T, Yamashita K, Takaori-Kondo A . Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis. Transpl Infect Dis 2013; 15: 195–201.

    CAS  PubMed  Google Scholar 

  62. Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P . HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant 2013; 48: 574–580.

    CAS  PubMed  Google Scholar 

  63. Quereda C, Corral I, Laguna F, Valencia ME, Tenorio A, Echeverria JE et al. Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol 2000; 38: 3061–3067.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Prasad A, Remick J, Zeichner SL . Activation of human herpesvirus replication by apoptosis. J Virol 2013; 87: 10641–10650.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Tang H, Serada S, Kawabata A, Ota M, Hayashi E, Naka T et al. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci USA 2013; 110: 9096–9099.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Gewurz BE, Marty FM, Baden LR, Katz JT . Human herpesvirus 6 encephalitis. Curr Infect Dis Rep 2008; 10: 292–299.

    PubMed  Google Scholar 

  67. Donati D, Martinelli E, Cassiani-Ingoni R, Ahlqvist J, Hou J, Major EO et al. Variant-specific tropism of human herpesvirus 6 in human astrocytes. J Virol 2005; 79: 9439–9448.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hahn A, Jacobson S . Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J Neurovirol 2005; 11: 384–394.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. De Filippis L, Foglieni C, Silva S, Vescovi A, Lusso P, Malnati MS . Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. J Clin Virol 2006; 37: S27–S32.

    CAS  PubMed  Google Scholar 

  70. Fotheringham J, Akhyani N, Vortmeyer A, Donati D, Williams E, Oh U et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007; 195: 450–454.

    CAS  PubMed  Google Scholar 

  71. Fotheringham J, Williams EL, Akhyani N, Jacobson S . Human herpesvirus 6 (HHV-6) induces dysregulation of glutamate uptake and transporter expression in astrocytes. J Neuroimmune Pharmacol 2008; 3: 105–116.

    PubMed  Google Scholar 

  72. The Japan Society for Hematopoietic Cell Transplantation (JSHCT) Monograph. 2012; 34 (Japanese). http://www.jshct.com/guideline/pdf/kansenkanri.pdf.

  73. Manichanh C, Grenot P, Gautheret-Dejean A, Debre P, Huraux JM, Agut H . Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry 2000; 40: 135–140.

    CAS  PubMed  Google Scholar 

  74. Akesson-Johansson A, Harmenberg J, Wahren B, Linde A . Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother 1990; 34: 2417–2419.

    CAS  PubMed  PubMed Central  Google Scholar 

  75. De Clercq E, Naesens L, De Bolle L, Schols D, Zhang Y, Neyts J . Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 2001; 11: 381–395.

    CAS  PubMed  Google Scholar 

  76. Yoshida M, Yamada M, Tsukazaki T, Chatterjee S, Lakeman FD, Nii S et al. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res 1998; 40: 73–84.

    CAS  PubMed  Google Scholar 

  77. Raffi F, Taburet AM, Ghaleh B, Huart A, Singlas E . Penetration of foscarnet into cerebrospinal fluid of AIDS patients. Antimicrob Agents Chemother 1993; 37: 1777–1780.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Williams-Aziz SL, Hartline CB, Harden EA, Daily SL, Prichard MN, Kushner NL et al. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. Antimicrob Agents Chemother 2005; 49: 3724–3733.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Bonnafous P, Bogaert S, Godet AN, Agut H . HDP-CDV as an alternative for treatment of human herpesvirus-6 infections. J Clin Virol 2013; 56: 175–176.

    PubMed  Google Scholar 

  80. De Bolle L, Andrei G, Snoeck R, Zhang Y, Van Lommel A, Otto M et al. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423. Biochem Pharmacol 2004; 67: 325–336.

    CAS  PubMed  Google Scholar 

  81. Prichard MN, Williams JD, Komazin-Meredith G, Khan AR, Price NB, Jefferson GM et al. Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses. Antimicrob Agents Chemother 2013; 57: 3518–3527.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Milbradt J, Auerochs S, Korn K, Marschall M . Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate. J Clin Virol 2009; 46: 24–28.

    CAS  PubMed  Google Scholar 

  83. Painter W, Robertson A, Trost LC, Godkin S, Lampert B, Painter G . First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother 2012; 56: 2726–2734.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Hakacova N, Klingel K, Kandolf R, Engdahl E, Fogdell-Hahn A, Higgins T . First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child. J Clin Virol 2013; 57: 157–160.

    PubMed  Google Scholar 

  85. Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med 2014; 6: 242ra283.

    Google Scholar 

  86. Tischer S, Priesner C, Heuft HG, Goudeva L, Mende W, Barthold M et al. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. J Transl Med 2014; 12: 336.

    PubMed  PubMed Central  Google Scholar 

  87. Becerra A, Gibson L, Stern LJ, Calvo-Calle JM . Immune response to HHV-6 and implications for immunotherapy. Curr Opin Virol 2014; 9: 154–161.

    CAS  PubMed  Google Scholar 

  88. Caserta MT, Dewhurst S . Dazed and confused by HHV-6. Blood 2011; 117: 5016–5018.

    CAS  PubMed  Google Scholar 

  89. Ward KN . Child and adult forms of human herpesvirus 6 encephalitis: looking back, looking forward. Curr Opin Neurol 2014; 27: 349–355.

    PubMed  Google Scholar 

  90. Ishiyama K, Katagiri T, Hoshino T, Yoshida T, Yamaguchi M, Nakao S . Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT. Bone Marrow Transplant 2011; 46: 863–869.

    CAS  PubMed  Google Scholar 

  91. Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med 2013; 369: 1227–1236.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by Health Labour Science Research grant (Grant Number H26-kakushintekigan-ippan-140).

Author information

Authors and Affiliations

  1. Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan

    M Ogata

  2. Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan

    T Fukuda

  3. Department of Hematology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    T Teshima

Authors
  1. M Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Teshima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Ogata.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogata, M., Fukuda, T. & Teshima, T. Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know. Bone Marrow Transplant 50, 1030–1036 (2015). https://doi.org/10.1038/bmt.2015.76

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.76

This article is cited by

Search

Advanced search

Quick links